1. Home
  2. FBP vs HAE Comparison

FBP vs HAE Comparison

Compare FBP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First BanCorp. New

FBP

First BanCorp. New

HOLD

Current Price

$26.36

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

HAE

Haemonetics Corporation

HOLD

Current Price

$105.79

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBP
HAE
Founded
1948
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.8B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
FBP
HAE
Price
$26.36
$105.79
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$25.50
★ $84.13
AVG Volume (30 Days)
★ 1.1M
460.8K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
★ 3.36%
N/A
EPS Growth
★ 18.78
N/A
EPS
★ 1.19
0.72
Revenue
★ $1,255,034,000.00
$910,373,000.00
Revenue This Year
$15.10
N/A
Revenue Next Year
$4.65
$5.23
P/E Ratio
★ $22.03
$146.50
Revenue Growth
★ 2.38
N/A
52 Week Low
$19.16
$47.75
52 Week High
$29.88
$110.45

Technical Indicators

Market Signals
Indicator
FBP
HAE
Relative Strength Index (RSI) 31.13 57.94
Support Level $25.72 $100.53
Resistance Level $26.94 $110.01
Average True Range (ATR) 0.53 2.49
MACD -0.13 -0.73
Stochastic Oscillator 3.90 49.90

Price Performance

Historical Comparison
FBP
HAE

About FBP First BanCorp. New

First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: